AI
RLAY icon

Alphabet Inc’s Relay Therapeutics RLAY Stock Holding History

Alphabet Inc’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.4M Sell
1,410,029
-154,144
-10% -$2.24M 0.03% 17
2026
Q1 		$15.6M Sell
1,564,173
-4,580
-0.3% -$41K 0.39% 15
2025
Q4 		$13.3M Hold
1,568,753
– – 0.51% 13
2025
Q3 		$8.19M Hold
1,568,753
– – 0.34% 19
2025
Q2 		$5.43M Hold
1,568,753
– – 0.25% 19
2025
Q1 		$4.11M Hold
1,568,753
– – 0.26% 21
2024
Q4 		$6.46M Hold
1,568,753
– – 0.38% 16
2024
Q3 		$11.1M Hold
1,568,753
– – 0.6% 14
2024
Q2 		$10.2M Hold
1,568,753
– – 0.52% 14
2024
Q1 		$13M Hold
1,568,753
– – 0.52% 15
2023
Q4 		$17.3M Hold
1,568,753
– – 0.8% 13
2023
Q3 		$13.2M Hold
1,568,753
– – 0.85% 14
2023
Q2 		$19.7M Hold
1,568,753
– – 1.06% 14
2023
Q1 		$25.8M Hold
1,568,753
– – 1.43% 15
2022
Q4 		$23.4M Hold
1,568,753
– – 1.36% 16
2022
Q3 		$35.1M Hold
1,568,753
– – 1.79% 14
2022
Q2 		$26.3M Hold
1,568,753
– – 1.43% 14
2022
Q1 		$47M Buy
1,568,753
+4,580
+0.3% +$111K 1.52% 15
2021
Q4 		$48M Sell
1,564,173
-77,324
-5% -$2.44M 1.16% 15
2021
Q3 		$51.8M Sell
1,641,497
-185,379
-10% -$6.24M 1.23% 14
2021
Q2 		$66.8M Buy
1,826,876
+258,390
+16% +$8.52M 1.36% 11
2021
Q1 		$54.2M Sell
1,568,486
-233,004
-13% -$10.1M 2.19% 9
2020
Q4 		$74.9M Hold
1,801,490
– – 3.59% 8
2020
Q3 		$76.7M Buy
+1,801,490
New +$68.7M 3.6% 5

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Alphabet Inc's RLAY Position: Q2 2026 in Review

Alphabet Inc reduced its Relay Therapeutics (RLAY) stake by 9.9% in Q2 2026, selling an estimated $2.24M and leaving 1,410,029 shares worth $26.4M. The position accounts for 0.03% of the portfolio, ranked #17.

Alphabet Inc first reported a position in RLAY in Q3 2020 and has held it in 24 quarters since. The position peaked at $76.7M in Q3 2020. 258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Alphabet Inc held 1,410,029 shares of Relay Therapeutics worth $26.4M as of Q2 2026.
  • Alphabet Inc sold 154,144 Relay Therapeutics shares in Q2 2026, an estimated $2.24M.
  • Relay Therapeutics made up 0.03% of Alphabet Inc's portfolio in Q2 2026, its #17 holding.
  • Alphabet Inc first reported a position in Relay Therapeutics in Q3 2020 and has held it in 24 quarters since.
  • Alphabet Inc's Relay Therapeutics position peaked at $76.7M in Q3 2020.
  • 258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Alphabet Inc's 13F filing for Q2 2026, filed 7 Aug 2026.